XT
CASI

XTX Topco’s CASI Pharmaceuticals CASI Stock Holding History

XTX Topco’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,132
Closed -$49K – 710
2021
Q3 		$49K Buy
4,132
+2,724
+193% +$36.8K 0.02% 606
2021
Q2 		$22K Sell
1,408
-14
-1% -$236 0.01% 763
2021
Q1 		$34K Buy
+1,422
New +$39.9K 0.02% 642

Other funds holding CASI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

XTX Topco's CASI Position: Q4 2021 in Review

XTX Topco sold out of CASI Pharmaceuticals (CASI) in Q4 2021, closing a stake of 4,132 shares — an estimated $49K sold.

XTX Topco first reported a position in CASI in Q1 2021 and held it in 3 quarters. The position peaked at $49K in Q3 2021. 51 funds tracked by Wall St. Rank hold CASI as of Q4 2021.

  • XTX Topco reported no remaining CASI Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • XTX Topco sold 4,132 CASI Pharmaceuticals shares in Q4 2021, an estimated $49K.
  • XTX Topco first reported a position in CASI Pharmaceuticals in Q1 2021 and held it in 3 quarters.
  • XTX Topco's CASI Pharmaceuticals position peaked at $49K in Q3 2021.
  • 51 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2021.

Based on XTX Topco's 13F filing for Q4 2021, filed 11 Feb 2022.